Table 3.
The KEGG analysis of breakpoints.
| ID | Description | P value | P adjust∗ |
|---|---|---|---|
| hsa05200 | Pathways in cancer | 0.009462254 | 0.585084485 |
| hsa05222 | Small cell lung cancer | 0.013923376 | 0.585084485 |
| hsa05220 | Chronic myeloid leukemia | 0.034615567 | 0.585084485 |
| hsa04810 | Regulation of actin cytoskeleton | 0.058285601 | 0.585084485 |
| hsa04330 | Notch signaling pathway | 0.077633762 | 0.585084485 |
| hsa04660 | T cell receptor signaling pathway | 0.089578675 | 0.585084485 |
| hsa00430 | Taurine and hypotaurine metabolism | 0.094228757 | 0.585084485 |
| hsa04340 | Hedgehog signaling pathway | 0.104655279 | 0.585084485 |
| hsa04623 | Cytosolic DNA-sensing pathway | 0.104655279 | 0.585084485 |
| hsa04670 | Leukocyte transendothelial migration | 0.107434188 | 0.585084485 |
∗All of FDR (adjusted P value) > 0.05, the potential reason was that the number of gene was too few, so the P value < 0.05 instead of FDR < 0.05 was the appropriate statistical analysis criteria to analyze the final result.